
New AI-generated COVID drug enters Phase I clinical trials: ‘Effective against all variants’
Fox News
Insilico Medicine recently announced that its new AI-designed drug for COVID-19 has entered Phase I clinical trials. If approved, it would become the first-ever alternative to Paxlovid.
This oral drug is a treatment, not a vaccine. If approved, it would become the first-ever alternative to Paxlovid, noted Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine. "Generative AI is transforming every area of human development." Melissa Rudy is health editor and a member of the lifestyle team at Fox News Digital.
"Generative AI is transforming every area of human development," said Zhavoronkov in a press release announcing the new discovery.

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












